12 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19234245 | TREATMENT OF DYSTROPHINOPATHIES WITH MICRODYSTROPHIN GENE THERAPY CONSTRUCTS | LEVIN, JOEL D | 1633 | Final Rejection | Jun 10, 2025 |
| 18559078 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY AND COMBINATIONS THEREOF | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Nov 06, 2023 |
| 18558495 | NOVEL AAV VECTORS AND METHODS AND USES THEREOF | NICOL, ALEXANDER W | 1634 | Non-Final OA | Nov 01, 2023 |
| 18261551 | IMPROVED PRODUCTION OF RECOMBINANT POLYPEPTIDES AND VIRUSES | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | Jul 14, 2023 |
| 18257820 | METHOD OF PRODUCING A RECOMBINANT VIRUS PARTICLE | LY, KRISTINA ELISABETH | 1671 | Non-Final OA | Jun 15, 2023 |
| 18034042 | VECTORIZED TNF-ALPHA ANTAGONISTS FOR OCULAR INDICATIONS | HUMPHRIES, NICHOLAS ADAM | 1631 | Non-Final OA | Apr 26, 2023 |
| 17638517 | TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FAB | PENNINGTON, KATIE LEIGH | 1634 | Non-Final OA | Feb 25, 2022 |
| 17628517 | ENGINEERED NUCLEIC ACID REGULATORY ELEMENT AND METHODS OF USES THEREOF | MATALKAH, FATIMAH KHALAF | 1638 | Final Rejection | Jan 19, 2022 |
| 17600377 | Gene Therapy For Eye Pathologies | PARAS JR, PETER | 1632 | Final Rejection | Sep 30, 2021 |
| 17292750 | GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES | ARON, KIMBERLY A | 1633 | Non-Final OA | May 11, 2021 |
| 17285362 | METHOD FOR MEASURING THE INFECTIVITY OF REPLICATION DEFECTIVE VIRAL VECTORS AND VIRUSES | YU, TIAN NMN | 1681 | Non-Final OA | Apr 14, 2021 |
| 17050942 | SYSTEMS AND METHODS OF SPECTROPHOTOMETRY FOR THE DETERMINATION OF GENOME CONTENT, CAPSID CONTENT AND FULL/EMPTY RATIOS OF ADENO-ASSOCIATED VIRUS PARTICLES | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | Final Rejection | Oct 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial